0 items USD 0.00Search
Your search for "ark patent intelligence caspofungin patent extension data exclusivity expiry snapshot 51" gave back 83388 results.
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development,...
Catalog:
IQ4I
May 2021
Price: USD 4,950.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive...
Catalog:
La Merie Publishing
November 2017
Price: USD 525.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
Catalog:
CBR Pharma Insights
July 2015
Price: USD 2,995.00
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Polymerase Chain Reaction (PCR) is a novel technique which doubles the amount of target DNA in every cycle. The PCR has three steps such as...
Catalog:
IQ4I
May 2016
Price: USD 4,500.00
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect...
Catalog:
IQ4I
March 2021
Price: USD 4,950.00
The global Echinocandins market size was valued at USD 1050.6 million in 2022 and is forecast to a readjusted size of USD 1289.1 million by 2029 with...
Catalog:
GIR
December 2023
Price: USD 3,480.00
The global Echinocandins for Injection market size was valued at USD 916.8 million in 2022 and is forecast to a readjusted size of USD 1184.9 million...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
